Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel Disease

作者: Guru Trikudanathan , Preethi G.K. Venkatesh , Udayakumar Navaneethan

DOI: 10.2165/11638120-000000000-00000

关键词:

摘要: Extra-intestinal manifestations (EIMs) are reported frequently in patients with inflammatory bowel disease (IBD) and may be diagnosed before, concurrently or after the diagnosis of IBD. EIMs IBD classified based on their association activity. The first group has a direct relationship activity includes pauciarticular arthritis, oral aphthous ulcers, erythema nodosum episcleritis. second appears to follow an independent course from underlying include ankylosing spondylitis uveitis. third that not related intestinal inflammation, such as pyoderma gangrenosum probably primary sclerosing cholangitis (PSC). Genetic susceptibility, aberrant self-recognition immunopathogenic autoantibodies against organ-specific cellular antigens shared by colon extra-colonic organs contribute pathogenesis development these EIMs. use biological agents armamentarium expanded treatment options for some disabling form cornerstone managing most PSC is one common hepatobiliary associated which no clear exist other than endoscopic therapy liver transplantation. Future research targeting pathogenesis, early required.

参考文章(111)
Ferenci P, Gangl A, Vogelsang H, Kiss A, Resch H, Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. European Journal of Gastroenterology & Hepatology. ,vol. 7, pp. 609- 614 ,(1995)
N. Tanaka, N. Ozono, H. Uchino, DEPARTMENT OF INTERNAL MEDICINE Proceedings of Research Institute for Nuclear Medicine and Biology (Japan). ,(1966)
J Sorstad, C Johansson, G Hellers, U Monsén, Extracolonic diagnoses in ulcerative colitis: an epidemiological study. The American Journal of Gastroenterology. ,vol. 85, pp. 711- 716 ,(1990)
M McKinley, F J Troncale, E A Petrelli, Ocular manifestations of inflammatory bowel disease. Annals of Ophthalmology. ,vol. 14, pp. 356- 360 ,(1982)
Debbie M Nathan, Peter W Angus, Peter R Gibson, Hepatitis B and C virus infections and anti‐tumor necrosis factor‐α therapy: Guidelines for clinical approach Journal of Gastroenterology and Hepatology. ,vol. 21, pp. 1366- 1371 ,(2006) , 10.1111/J.1440-1746.2006.04559.X
C. K. Triantos, N. M. Koukias, V. N. Nikolopoulou, A. K. Burroughs, Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis Alimentary Pharmacology & Therapeutics. ,vol. 34, pp. 901- 910 ,(2011) , 10.1111/J.1365-2036.2011.04822.X
Katja S Rothfuss, Eduard F Stange, Klaus R Herrlinger, Extraintestinal manifestations and complications in inflammatory bowel diseases World Journal of Gastroenterology. ,vol. 12, pp. 4819- 4831 ,(2006) , 10.3748/WJG.V12.I30.4819
S Ardizzone, P Sarzi Puttini, A Cassinotti, G Bianchi Porro, Extraintestinal Manifestations of Inflammatory Bowel Disease Gastroenterología y Hepatología. ,vol. 7, pp. 235- 241 ,(2011)
N. McConnell, S. Campbell, I. Gillanders, H. Rolton, B. Danesh, Risk factors for developing renal stones in inflammatory bowel disease. BJUI. ,vol. 89, pp. 835- 841 ,(2002) , 10.1046/J.1464-410X.2002.02739.X
GR Oliveira, BCV Teles, É F Brasil, MHLP Souza, LETA Furtado, CM de Castro-Costa, FH Rola, LLBC Braga, F de AA Gondim, None, Peripheral neuropathy and neurological disorders in an unselected Brazilian population-based cohort of IBD patients Inflammatory Bowel Diseases. ,vol. 14, pp. 389- 395 ,(2008) , 10.1002/IBD.20304